Loading...

Guardant Health, Inc.

GH•NASDAQ
Healthcare
Medical - Diagnostics & Research
$88.91
$1.04(1.18%)
U.S. Market opens in 23h 4m

Guardant Health, Inc. (GH) Stock Overview

Explore Guardant Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.7B
P/E Ratio-28.08
EPS (TTM)$-3.32
ROE1.65%
Fundamental Analysis

AI Price Forecasts

1 Month$96.60
3 Months$126.88
1 Year Target$138.31

GH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Guardant Health, Inc. (GH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.02, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $138.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.08 and a market capitalization of 11.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.18%
5-Day Change
2.61%
1-Month Change
6.36%
3-Month Change
-22.52%
6-Month Change
23.23%
Year-to-Date (YTD) Change
-12.95%
1-Year Change
87.53%
3-Year Change
285.39%
5-Year Change
-46.34%
All-Time (Max) Change
176.12%

Contact Information

https://guardanthealth.com
855 698 8887
505 Penobscot Drive, Palo Alto, CA, 94063

Company Facts

1,999 Employees
IPO DateOct 4, 2018
CountryUS
Actively Trading

Frequently Asked Questions